e-Drug3D

1393

INAMRINONE


INN
INAMRINONE

cas 60719-84-8
CLASS

CARDIOVASCULAR
PHOSPHODIESTERASE INHIBITORS
VASODILATOR AGENTS
CARDIOTONIC

ROUTE (list)

INJECTION

ATC code

C01CE01

PK parameters

VD 84.5 LITER (65 KILOGRAM)
Cl 34.7 LITER / HOUR (65 KILOGRAM)
PPB 11 PERCENT
t1/2 2 HOUR

Target

TARGET PHOSPHODIESTERASE 3

DrugCentral

cGMP-inhibited 3,5-cyclic phosphodiesterase A UNIPROT Q14432 PDE3A

Download SDF file 3-amino-5-pyridin-4-yl-1H-pyridin-2-one

Formula:
C10H9N3O

Calculated chemical properties:

MW 187.20
NB_atoms 14
XLogP 1.02
PSA 64.663
NB_HD 3
NB_HA 4
fsp3 0.00
Lipinski(0=no;1=yes) 1

FDA
NDA 018700 (pdf not found) INN (INAMRINONE LACTATE) INOCOR (SANOFI AVENTIS US) APPROVAL= AP YEAR= 1984 DISCONTINUED
NDA 074616 (pdf not found) INN (INAMRINONE LACTATE) AMRINONE LACTATE (HOSPIRA) APPROVAL= AP YEAR= 1998 DISCONTINUED
NDA 075513 (pdf not found) INN (INAMRINONE LACTATE) AMRINONE LACTATE (HIKMA) APPROVAL= AP YEAR= 2000
NDA 075542 (pdf not found) INN (INAMRINONE LACTATE) AMRINONE LACTATE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2000 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL